NCT00400777View on ClinicalTrials.gov

Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

June 30, 2008

Conditions
Hypertension
Interventions
DRUG

Valsartan, hydrochlorothiazide and amlodipine

Trial Locations (1)

RJ 20551-030

Novartis, Rio de Janeiro

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY